Biogen Idec (NASDAQ:BIIB)

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

The stock market has experienced yet another 5% correction after hitting all-time highs just in July. What really stands out for 2019, particularly if you just followed the emotions of ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, July 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Why Biogen’s Q2 Was So Great

When Biogen Inc. (NASDAQ: BIIB) released its second-quarter financial results before the markets opened on Tuesday, the biotech giant said that it had $9.15 in earnings per share (EPS) and ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, June 28. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle, McDonald’s, Nike, Procter & Gamble, Walgreens and More

It seems impossible to fathom, but this is the last day of the second quarter in 2019. The bull market is well into its 10th year, and the major indexes ...
Read Full Story »

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, June 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Big Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Although the broad markets have been in a slump recently amid China trade talks, the S&P 500 and Dow futures for Tuesday morning were relatively positive. While there has been ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, Anadarko, Beyond Meat, Boeing, Ctrip.com, GW Pharma, Roku, Texas Instruments, Veeco and More

Stocks were indicated to open lower on Tuesday, but nowhere close to the opening bell drop indications seen on Monday's "sell China" day. With many investors wondering if they should ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, April 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Big Biotechs Confound Short Sellers

The short interest data are out for the most recent settlement date, March 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »